These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 193145)

  • 21. [Toxicity and antiradiation activity of aminopropyl aminoethyl thiophosphate].
    Terekhov AV; Besedina LN; Zherebchenko PG; Znamenskiĭ VV; Suslikov VI; Titov BA
    Radiobiologiia; 1976; 16(2):249-52. PubMed ID: 189349
    [No Abstract]   [Full Text] [Related]  

  • 22. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
    Murray D; Altschuler EM; Hunter N; Milas L
    Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of normal tissues by WR2721 during fractionated irradiation.
    Utley JF; Phillips TL; Kane LJ
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):699-703. PubMed ID: 185172
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the radioprotective effectiveness of certain aminoalkylthiophosphoric derivatives. 3. Study of the radioprotective effectiveness of S-[S-thioethyl-2-amino-N-(3-aminopropyl)] thiophosphoric acid].
    Sverdlov AG; Grachev SA; Bondarev GN; Bogatyrev AV; Nikanorova NG
    Radiobiologiia; 1980; 20(2):269-72. PubMed ID: 6250188
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in spermatid population of mouse following radiation exposure in the presence of a thiophosphate.
    Jaimala ; Bhartiva HC
    J Nucl Med Allied Sci; 1987; 31(3):261-4. PubMed ID: 2826724
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of iodoacetamide and X rays on a murine ascites tumor.
    Feola JM
    Radiat Res; 1977 Apr; 70(1):118-29. PubMed ID: 850726
    [No Abstract]   [Full Text] [Related]  

  • 27. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies of cancer radiotherapy by combined use of radioprotectors and a radiosensitizer].
    Oshima T; Tsukiyama I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1973 Apr; 33(4):351-9. PubMed ID: 4517309
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.
    Brown JM; Yu NY; Cory MJ; Bicknell RB; Taylor DL
    Br J Cancer Suppl; 1978 Jun; 3():206-11. PubMed ID: 277229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Restorative inhibition of radiation injureis by chemical compounds as a method of increasing the effectiveness of the radiotherapy of tumors].
    Pelevina II
    Med Radiol (Mosk); 1977 Feb; 22(2):8-13. PubMed ID: 859396
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of S-2(3-aminopropylamino) ethyl phosphorothioic acid on ATPase activity in the testis of irradiated mouse.
    Jaimala ; Bhartiya HC
    Radiobiol Radiother (Berl); 1986; 27(4):485-9. PubMed ID: 3022328
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
    McNally NJ
    Br J Cancer; 1982 Oct; 46(4):670-4. PubMed ID: 6291565
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection of bone marrow by WR-2721 after fractionated irradiation.
    Coia LR; Brown DQ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):908-9. PubMed ID: 2550401
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of a combination of cystaphos and mexamine on changes in the hematopoietic system in multiple irradiations].
    Kavukchian TV; Bogatyrev AV; Nikanorova NG; Sverdlov AG
    Radiobiologiia; 1973; 13(6):933-7. PubMed ID: 4780561
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioprotection of mouse testis by S-2-(3-aminopropylamino)ethylphosphorothioic acid.
    Bhartiya J; Bhartiya HC
    Radiobiol Radiother (Berl); 1985; 26(3):389-93. PubMed ID: 2997832
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of nitroaromatic compounds as hypoxic cell radiosensitizers.
    Wardman P
    Curr Top Radiat Res Q; 1977 Aug; 11(4):347-98. PubMed ID: 330116
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined radiosensitization and radioprotection for oral cavity tumors: study with an oral cavity tumor model.
    Grigsby P; Maruyama Y
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):557-9. PubMed ID: 6286553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
    Akagi K; Sogawa M; Tanaka Y
    Gan No Rinsho; 1983 Oct; 29(13):1613-8. PubMed ID: 6668669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 2. Abdominal and pelvic tumors].
    Niibe H; Takahashi I; Miyaishi K; Mitsuhashi N; Maehara Y; Nakajima N; Suto H; Saito Y; Yamakawa M; Sugiyama S
    Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):994-1001. PubMed ID: 2997352
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
    Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
    Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.